Skip to Main Content

Author Details

Johna Lucas
1997
17
9
PMIDPaper TitleJournal TitlePublished Year
35147466Safety Profile of Bremelanotide Across the Clinical Development Program.Journal of Women's Health2022
35230162Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.Journal of Women's Health2022
34559353Psychometric validation of the Female Sexual Distress Scale-Desire/Arousal/Orgasm.Journal of Patient-Reported Outcomes2021
33538638The Patient Experience of Premenopausal Women Treated with Bremelanotide for Hypoactive Sexual Desire Disorder: RECONNECT Exit Study Results.Journal of Women's Health2021
33835907Failure of a Meta-analysis: A Commentary on Glen Spielmans's "Re-Analyzing Phase III Bremelanotide Trials for 'Hypoactive Sexual Desire Disorder in Women'".Journal of Sex Research2021
33033885Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder.Journal of Patient-Reported Outcomes2020
31277966Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.Journal of Sexual Medicine2019
31599847Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.Obstetrics and Gynecology2019
31599840Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.Obstetrics and Gynecology2019
27977473Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide.Journal of Hypertension2017
28189361Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants.Clinical Therapeutics2017
27181790Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial.Women's Health2016
23802867Characterization of orgasmic difficulties by women: focus group evaluation.Journal of Sexual Medicine2013
21142609Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen.Gynecological Endocrinology2011
16043675Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.2005
16014407Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.J Clin Endocrinol Metab2005
9531230Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group.1997
  • 1 - 17 of 17

Recommended Authors

Collaborators

Sheryl A Kingsberg
Co-authored papers 8
James A Simon
Co-authored papers 8
Anita H Clayton
Co-authored papers 8
Leonard R Derogatis
Co-authored papers 5
Stanley E Althof
Co-authored papers 3
Cynthia Rodenberg
Co-authored papers 2
Lila Nachtigall
Co-authored papers 2
Molly Katz
Co-authored papers 2
Akshay Buch
Co-authored papers 2
Glenn D Braunstein
Co-authored papers 2
Susan R Davis
School of Public Health and Preventive Medicine, Monash University
Co-authored papers 1
Christine Derzko
Co-authored papers 1
Arthur S Waldbaum
Co-authored papers 1
Céline Bouchard
Co-authored papers 1
Jan L Shifren
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Sam Miller
Co-authored papers 1
Irwin Goldstein
Co-authored papers 1
Wulf H Utian
Co-authored papers 1
Robin Kroll
Co-authored papers 1
Raymond C Rosen
Co-authored papers 1
Release 1.2